Last reviewed · How we verify

NCT06278376

Evaluation of Diagnoses and Clinical Outcomes in Children Undergoing MRI Scans

Completed Last updated 14 May 2025
What this trial tests

trial in Magnetic Resonance Imaging in 410 participants. Completed in 31 December 2024.

Timeline
25 April 2023
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorJessa Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment410
Start date25 April 2023
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Belgium

Conditions studied

Sponsor

Jessa Hospital

Who can join

Adults 6 Months to 16, any sex, with Magnetic Resonance Imaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the indications and therapeutical consequences of MRI scans of (young) children undergoing risky remote anaesthesia. The investigators want to aim for a clear indication in children undergoing MRI in the future before undergoing possible unnecessary procedures and MRI scans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Magnetic Resonance Imaging

Currently open trials in the same condition.

Other Jessa Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06278376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing